Venous thromboembolism (VTE) is a medical condition where blood coagulation happens most frequently in the veins of the limb, crotch, or arm. The most dreaded complication of deep vein thrombosis (DVT) is pulmonary embolism (PE), possibly lethal. The incidence of VTE in India was 17.46 per 10,000 hospital admissions. Given the high incidence, the current study was undertaken. The present study was done with the aim to know the prevalence of administration of prophylaxis of DVT in postoperative patients using a risk assessment card at a tertiary care centre named Siddhartha Medical College, Vijayawada, Andhra Pradesh, in India. Objectives of the study include studying the impact of DVT risk assessment cards on the prevalence rates of prophylaxis administration in postoperative patients and establishing the current rates of thromboprophylaxis in post-operative surgical patients. This observational study was done on 60 patients scheduled for various surgeries from July 2020 to December 2022. 60 patients were randomized into groups: A and B, each containing 30 patients, depending on the phase. Group A (Phase 1) included patients before introducing the risk assessment card for DVT. Group B (Phase II) included patients after introducing the risk assessment card for DVT. Results showed that most patients in both study phases were aged below 40 years. Most of the patients were males. Most of the patients belonged to the low-risk category. The two groups have no significant difference in the mean risk score. Mechanical and drug prophylaxis incidence was significantly higher in group B or phase II patients. Introducing risk assessment cards for DVT for Inpatient (IP) case sheets was an effective and cost-effective way of improving overall prophylaxis for DVT.

1. Stein PD, Matta F, Musani MH, Diaczok B. Silent pulmonary embolism in patients with deep venous thrombosis: a systematic review. Am J Med. 2010 May 1;123(5):426-31. doi: 10.1016/j.amjmed.2009.09.037, PMID 20399319.
2. Kearon C. Natural history of venous thromboembolism. Circulation. 2003;107(23);Suppl 1:I22-30. doi: 10.1161/01.CIR.0000078464.82671.78, PMID 12814982, Google Scholar.
3. Ho WK. Deep vein thrombosis–risks and diagnosis. Aust Fam Physician. 2010;39(7):468-74. PMID 20628659, Google Scholar.
4. Gibbs H, Fletcher J, Blombery P, Collins R, Wheatley D. Venous thromboembolism prophylaxis guideline implementation is improved by nurse directed feedback and audit. Thromb J. 2011;9(1):7. (PMC Free article). doi: 10.1186/1477-9560-9-7, PMID 21466681, Google Scholar.
5. Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5(4):692-9. doi: 10.1111/j.1538-7836.2007.02450.x, PMID 17367492, Google Scholar.
6. Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol. 2007 Apr;44(2):62-9. doi: 10.1053/j.seminhematol.2007.02.004, PMID 17433897, PMCID PMC2020806.
7. National Health and Medical Research Council. National Health and Medical Research Council; 2011. Stop the clot: integrating VTE prevention guideline recommendations into routine hospital care. 3rd ed. Available from: http://www.nhmrc.gov.au/ [cited 12/6/2023]. Google Scholar.
8. Scarvelis D, Wells PS. Diagnosis and treatment of deep-vein thrombosis. CMAJ. 2006;175(9):1087-92. (PMC Free article). doi: 10.1503/cmaj.060366, PMID 17060659, Google Scholar.
9. Snow V, Qaseem A, Barry P, Hornbake ER, Rodnick JE, Tobolic T, et al. Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med. 2007;146(3):204-10. doi: 10.7326/0003-4819-146-3-200702060-00149, PMID 17261857, Google Scholar.
10. Kahn SR. The post thrombotic syndrome. Thromb Res. 2011;127;Suppl 3:S89-92. doi: 10.1016/S0049-3848(11)70024-X, PMID 21262451, Google Scholar.
11. Prince M, Wenham T. Heparin-induced thrombocytopaenia. Postgrad Med J. 2018 Aug;94(1114):453-7. doi: 10.1136/postgradmedj-2018-135702, PMID 30126928.
12. Gajic-Veljanoski O, Phua CW, Shah PS, Cheung AM. Effects of long-term low-molecular-weight heparin on fractures and bone density in non-pregnant adults: A systematic review with meta-analysis. J Gen Intern Med. 2016 Aug;31(8):947-57. (PMC Free article). doi: 10.1007/s11606-016-3603-8, PMID 26895998.
13. Levesque H, Verdier S, Cailleux N, Elie-Legrand MC, Gancel A, Basuyau JP et al. Low molecular weight heparins and hypoaldosteronism. BMJ. 1990 Jun 02;300(6737):1437-8. (PMC Free article). doi: 10.1136/bmj.300.6737.1437, PMID 2165831.
14. Abdol Razak NB, Jones G, Bhandari M, Berndt MC, Metharom P. Cancer-associated thrombosis: an overview of mechanisms, risk factors, and treatment. Cancers (Basel). 2018 Oct 11;10(10):380. doi: 10.3390/cancers10100380, PMID 30314362, PMCID PMC6209883.
15. Lee AD, Stephen E, Agarwal S, Premkumar P. Venous thrombo-embolism in India. Eur J Vasc Endovasc Surg. 2009 Apr;37(4):482-5. doi: 10.1016/j.ejvs.2008.11.031. PMID 19208449.
16. Khalil J, Bensaid B, Elkacemi H, Afif M, Bensaid Y, Kebdani T et al. Venous thromboembolism in cancer patients: an underestimated major health problem. World J Surg Oncol. 2015 Jun 20;13:204. doi: 10.1186/s12957-015-0592-8, PMID 26092573, PMCID PMC4486121.
17. Muleledhu AL, Galukande M, Makobore P, Mwambu T, Ameda F, Kiguli-Malwadde E. Deep venous thrombosis after major abdominal surgery in a Ugandan hospital: a prospective study. Int J Emerg Med. 2013;6(1):43. doi: 10.1186/1865-1380-6-43, PMID 24286162.
18. Pandey A, Patni N, Singh M, Guleria R. Assessment of risk and prophylaxis for deep vein thrombosis and pulmonary embolism in medically ill patients during their early days of hospital stay at a tertiary care center in a developing country. Vasc Health Risk Manag. 2009;5:643-8. doi: 10.2147/vhrm.s6416. PMID 19688105, PMCID PMC2725797.
19. Guyatt GH, Cook DJ, Jaeschke R, Pauker SG, Schünemann HJ. Grades of recommendation for antithrombotic agents: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest. 2008 Jun 1;133(6);Suppl:123S-31S. doi: 10.1378/chest.08-0654, PMID 18574262.
20. Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371(9610):387-94. doi: 10.1016/S0140-6736(08)60202-0, PMID 18242412, Google Scholar.
21. Al-Ogaili A, Quintero LD, Adum JPS, Fuentes HE, Caprini J. Venous thromboembolism risk stratification: the missing link in hospitalized patients. J Atheroscler Thromb. 2018 Nov 1;25(11):1087-8. doi: 10.5551/jat.ED096. PMID 29731505, PMCID PMC6224207.
22. Lee AD, Stephen E, Agarwal S, Premkumar P. Venous thrombo-embolism in India. Eur J Vasc Endovasc Surg. 2009 Apr;37(4):482-5. doi: 10.1016/j.ejvs.2008.11.031. PMID 19208449.
23. Cohen AT, Gitt AK, Bauersachs R, Fronk EM, Laeis P, Mismetti P, et al. The management of acute venous thromboembolism in clinical practice. Results from the European PREFER in VTE Registry. Thromb Haemost. 2017 Jul;117(7):1326-37. doi: 10.1160/TH16-10-0793, PMID 28405675.
24. Anderson DR, Morgano GP, Bennett C, Dentali F, Francis CW, Garcia DA, et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv. 2019;3(23):3898-944. doi: 10.1182/bloodadvances.2019000975, PMID 31794602.
25. Ortel TL, Neumann I, Ageno W, Beyth R, Clark NP, Cuker A, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;4(19):4693-738. doi: 10.1182/bloodadvances.2020001830, PMID 33007077.
26. Anderson DR, Morgano GP, Bennett C, Dentali F, Francis CW, Garcia DA, et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv. 2019 Dec 10;3(23):3898-944. doi: 10.1182/bloodadvances.2019000975, PMID 31794602, PMCID PMC6963238.
27. Bell EJ, Lutsey PL, Basu S, Cushman M, Heckbert SR, Lloyd-Jones DM et al. Lifetime risk of venous thromboembolism in two cohort studies. Am J Med. 2016 Mar;129(3):339.e19-26. (PMC Free article). doi: 10.1016/j.amjmed.2015.10.014, PMID 26597668.
28. Zakai NA, McClure LA, Judd SE, Safford MM, Folsom AR, Lutsey PL et al. Racial and regional differences in venous thromboembolism in the United States in 3 cohorts. Circulation. 2014 Apr 08;129(14):1502-9. (PMC Free article). doi: 10.1161/CIRCULATIONAHA.113.006472, PMID 24508826.
29. Faria C, Antunes H, Pontes T, Antunes A, Martins S, Carvalho S. Deep venous thrombosis of lower limbs in adolescents: a study in a tertiary hospital. Int J Adolesc Med Health. 2019 Feb 01;33(2). doi: 10.1515/ijamh-2018-0137, PMID 30707683.
30. Toker S, Hak DJ, Morgan SJ. Deep vein thrombosis prophylaxis in trauma patients. Thrombosis. 2011;2011:505373. doi: 10.1155/2011/505373. PMID 22084663, PMCID PMC3195354.
31. Fui D, Yap S, Clin M, Zhi Y, Chier Y, Saifuzzaman M, et al. Appropriateness of deep vein thrombosis (DVT) prophylaxis use among medical inpatients: a DVT risk alert tool (DRAT) study [internet] [cited Apr 5 2023]. Available from: E-mjm.org. Available from: https://www.e-mjm.org/2019/v74n1/deep-vein-thrombosis.pdf.
32. Zhou H, Hu Y, Li X, Wang L, Wang M, Xiao J et al. Assessment of the risk of venous thromboembolism in medical inpatients using the Padua prediction score and Caprini risk assessment model. J Atheroscler Thromb. 2018;25(11):1091-104. (PMC Free article). doi: 10.5551/jat.43653, PMID 29540637, Google Scholar.
33. Fritz MK, Kincaid SE, Sargent CG, Green AH, Davis GA. Venous thromboembolism (VTE) risk stratification in general medical patients at an academic medical center. J Thromb Thrombolysis. 2021;51(1):67-73. doi: 10.1007/s11239-020-02144-1, PMID 32447745.
34. Le Mao R, Orione C, de Moreuil C, Tromeur C, Hoffmann C, Fauché A, et al. Risk stratification for predicting recurrent venous thromboembolism after discontinuation of anticoagulation: a post hoc analysis of a French prospective multicentre study. Eur Respir J. 2022;60(3):2103002. doi: 10.1183/13993003.03002-2021, PMID 35210315.